Region 7 Dinner | NUPLAZID

Acadia Pharmaceuticals invites you to attend a Live Speaker Program.

NUPLAZID® (pimavanserin) is the first and only prescription medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.

Facilitator: Theresa Rowry DNP, MSL
To register email Theresa Rowry at theresa.rowry@acadia-pharm.com. If you have any questions, please feel free to contact Yolonda Freeman-Hildreth at 248-346-7470.